The United States Patent and Trademark Office (USPTO) attended a cross-training event hosted by the U.S. Food and Drug Administration (FDA). The training covered an overview of FDA approval pathways, FDA information disclosure policies and procedures, and publicly available FDA databases, including publicly available information about drug labeling and Advisory Committee materials.
Accessibility accommodation
Accessibility
If you are an individual with a disability and would like to request a reasonable accommodation, please submit your request to the contact information listed above.
CLE Header
This event is part of a series: USPTO-FDA joint initiative